Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
07-Jul-2011 -
Metamark Genetics, a privately-held oncology molecular diagnostic company, and Definiens announced a development and commercialization partnership in which Metamark will combine its proprietary multiplex protein detection platform with image analysis technology developed jointly with Definiens to ...
biomarker
cancer diagnostics
Metamark Genetics